ICD DEVICES

CONNECTED THROUGH LIFE

Healthcare Professionals Cardiac Rhythm Management ICD devices

Ulys™

Enhanced intelligence for optimal outcomes

Ulys™ features proven and physiological algorithms, reducing unnecessary and inappropriate therapies paving the way to improve clinical outcomes and provides continuous, advanced patient care.1-2

Features

  • Outstanding longevity3 – Protects your patients from early replacements and associated complications.4
  • PARAD+™ including the Long Cycle Search – Achieves the lowest rate of inappropriate shocks ever reported in literature.1
  • BTO™ – Brady Tachy Overlap. Supports patient exercise and detects slow ventricular tachycardia simultaneously.
  • SafeR™ – Eliminates deleterious right ventricular overstimulation.2
  • WARAD™ – Window of Atrial Rate Acceleration Detection. Accurately detects AF even in case of undersensing using a dynamic atrial window.5
  • Remote monitoring with SmartView™ monitor – Offers advanced patient monitoring and follow-up, providing timely alerts and detailed reports.

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.

Click here to know more
ICD devices ULYS DR 2540 front 05x 1

Edis™

Adaptive technology for streamlined workflow and advanced patient care

Edis™ guarantees continuous, advanced patient care, while device dimensions, design, and preset programming make implantation and follow-up effortless.

Features

  • Outstanding longevity1 – Frees you from early replacements and associated complications.2
  • PARAD+™ including the Long Cycle Search – Achieves the lowest rate of inappropriate shocks ever reported in literature.3
  • BTO™ – Brady Tachy Overlap. Supports patient exercise and detects slow ventricular tachycardia simultaneously.
  • SafeR™ – Eliminates deleterious right ventricular overstimulation.4
  • Remote monitoring with SmartView™ monitor – Offers efficient access to patient data that keeps your patients out of hospital.

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.

Click here to know more
ICD devices EDIS DR 2440 front 05x 2

PlatiniumTM

Enter a new era of longevity1

Thanks to its proven therapeutic functions2,3, Platinium™ is ready to protect your patients year after year and was designed to facilitate the implant experience and improve patient comfort.

Features

  • World’s greatest projected longevity1 – Protects your patients from early replacements.
  • PARAD+™ – World’s first dual-chamber arrhythmia discrimination algorithm. Best-in-class 99% overall specificity.2
  • SafeR™ – Manages all types of AV block. More than 96% preserved intrinsic conduction.3
Click here to know more
ICD devices Platinium VR 3
Parad

PARAD+TM

is the world’s first discrimination algorithm protecting patients from inappropriate shocks for over 20 years.

Discover this therapy
BTO

Brady Tachy Overlap (BTOTM)

allows the patient to benefit from ventricular pacing during exercise while maintaining slow VT detection and therapy.

Discover this therapy

TECH CORNER

PICTO Paper article

SafeR Pacing Mode

SafeR is the only AV management algorithm which has been proven to strongly reduce ventricular pacing for AV block patients as well as for SND patients. SafeR reduces the risk of HF hospitalization or cardiac death by 51%. It is designed to intelligently manage AV conduction, diagnosing all types of AV blocks and has been proven to be safe and effective for all brady patients.

Click here for full article
PICTO Paper article

Window of Atrial Rate Acceleration Detection (WARAD)

The WARAD is designed to monitor the atrial activity in order to discriminate pathological atrial waves (Atrial Fibrillation, Atrial Flutter, Atrial Tachycardias) from sinus P waves. This atrial discriminator uses atrial prematurity to trigger mode switching.

Click here for full article
PICTO Paper article

Fallback Mode Switch (FMS)

The FMS function is designed to diagnose atrial arrhythmias and manage their occurrence using the WARAD (Window of Atrial Rate Acceleration Detection): in the event of atrial arrhythmia, FMS switches from DDD®, SafeR® or Dplus® pacing mode to an inhibited dual- chamber pacing mode DDI® to avoid prolonged ventricular pacing at a high rate for the entire duration of the sustained atrial arrhythmia.

Click here for full article
PICTO Paper article

Anti-PMT (Pacemaker Mediated Tachycardia) algorithm

The Anti-PMT algorithm is intended to protect the patient from Pacemaker-Mediated Tachycardia (PMT) without reducing the atrial sensing capability of the device.

Click here for full article
PICTO Paper article

Tachyarrhythmia Suspicion and Detection

The primary goal of an Implantable Cardioverter Defibrillator (ICD) is to preserve life by terminating life-threatening ventricular tachycardia (VT) or ventricular fibrillation (VF).

The secondary goal is to deliver therapy only when required and always in the least obtrusive manner.

The third goal is to deliver therapy as painless as possible by giving priority to ATP.

The challenge for any device is to determine whether an elevated ventricular rate corresponds to a true ventricular tachyarrhythmia requiring device therapy or not (in the event that the elevated rate is not of ventricular origin).

Click here for full article
PICTO Paper article

PARAD/PARAD+ : P and R Based Arrhythmia Detection

The proper detection of VT requires a specific algorithm (arrhythmia discrimination) to discriminate ventricular tachycardia from Supraventricular tachycardia (SVT) or sinus tachycardia (ST). The MicroPort core algorithms used for rhythms within the VT zone are called PARAD and PARAD+.

Click here for full article
PICTO Paper article

ATP in the Fast VT zone

The fast VT zone offers the possibility to attempt painless ATP to terminate fast ventricular arrhythmias in a defined portion of the VF zone.

Click here for full article
PICTO Paper article

Automatic Ventricular Sensitivity Control (ASC)

The ASC is an essential of sensing used in MicroPort Implantable Cardiac Defibrillators to ensure appropriate sensing for all ventricular rhythms at all rates. It dynamically adapts the sensitivity to the changing endocardial signal in an attempt to detect each and every R wave.

Click here for full article
PICTO Paper article

Brady Tachy Overlap (BTO)

Brady-Tachy Overlap (BTO) is a function which starts as soon as the pacing zone and the Slow VT detection zone overlap by programming the maximum pacing rate faster than the slow VT detection rate. It allows the patient to benefit from biventricular (CRT-D) and ventricular (ICD) pacing during exercise while maintaining slow VT detection and therapy if programmed.

Click here for full article
PICTO Paper article

Alerts – System, Lead, Tachy Therapy and Clinical Alerts

In patients’ daily life, some clinical or device-related events need to be communicated to the physician or someone in the hospital or clinic’s team. Alerts are ALWAYS programmed through the programmer. They are triggered automatically by the device when the selected event occurs.

Click here for full article

MICROPORT® Manuals

http://www.microportmanuals.com/

Refer to user’s manual supplied with the device for complete instructions for use, intended use and relevant warnings, precautions, side effects, and contraindications.

Availability of products and functions vary by country. Please check with your representative for further information.


ULYS™ REFERENCES

  1. Ruiz-Granell R, Dovellini EV, Dompnier A, et al. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435.
  2. Kolb C, Sturmer M, Sick P, et al. Reduced risk for inappropriate implantable cardioverter defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail. 2014 Dec;2(6):611-619.
  3. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  4. Borleffs CJ, Thijssen J, de Bie MK, et al. Recurrent implantable cardioverter defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010 Aug;33(8):1013-1019.
  5. Bonnet JL, Brusseau E, Limousin M, et al. Mode switch despite undersensing of atrial fibrillation in DDD pacing. Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1724-8.

EDISREFERENCES

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  2. Borleffs CJ, Thijssen J, de Bie MK, et al. Recurrent implantable cardioverter defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010 Aug;33(8):1013-1019.
  3. Ruiz-Granell R, Dovellini EV, Dompnier A, et al. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435.
  4. Kolb C, Sturmer M, Sick P, et al. Reduced risk for inappropriate implantable cardioverter defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail. 2014 Dec;2(6):611-619.

PLATINIUMREFERENCES

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  2. Hintringer F, Deibl M, Berger T, et al. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004 Jul;27(7):976-982.
  3. Kolb C, Sturmer M, Sick P, et al. Reduced risk for inappropriate implantable cardioverter defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail. 2014 Dec;2(6):611-619.

Last Updated September 2021